Matches in Wikidata for { <http://www.wikidata.org/entity/Q74572203> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q74572203 description "artículu científicu espublizáu n'agostu de 2002" @default.
- Q74572203 description "im August 2002 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74572203 description "scientific article published on 01 August 2002" @default.
- Q74572203 description "wetenschappelijk artikel" @default.
- Q74572203 description "наукова стаття, опублікована в серпні 2002" @default.
- Q74572203 name "Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis" @default.
- Q74572203 name "Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis" @default.
- Q74572203 type Item @default.
- Q74572203 label "Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis" @default.
- Q74572203 label "Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis" @default.
- Q74572203 prefLabel "Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis" @default.
- Q74572203 prefLabel "Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis" @default.
- Q74572203 P1433 Q74572203-5105A253-84B6-4C3E-9D9D-5212AEDD2E31 @default.
- Q74572203 P1476 Q74572203-C115A4EC-13EA-4818-95A6-83BD2499F033 @default.
- Q74572203 P2093 Q74572203-580848E3-A1C5-4219-A91B-CAA25E8F1DA4 @default.
- Q74572203 P2093 Q74572203-8A02B7F5-E9B3-4F4D-8F69-D158E1922A7E @default.
- Q74572203 P304 Q74572203-1620D611-C067-43EE-B2AC-F16ECC00D9D7 @default.
- Q74572203 P31 Q74572203-CC82AABA-CE16-4CBC-AA30-A10A4CCC5600 @default.
- Q74572203 P356 Q74572203-D8F82650-43A2-4573-8DC4-4B2CE8A9335E @default.
- Q74572203 P407 Q74572203-E4CB4080-DD86-40AB-9D91-2BE50FEFF5C1 @default.
- Q74572203 P433 Q74572203-AB8943F0-2748-4061-92DB-A4D8F7E91BF4 @default.
- Q74572203 P478 Q74572203-C6D73909-B6C5-4DE4-B7AE-E6F696EE878D @default.
- Q74572203 P50 Q74572203-9F96B9CB-ADDC-4590-9CFC-228D902875F0 @default.
- Q74572203 P577 Q74572203-04A5EB95-043A-414A-849E-4676F8095C45 @default.
- Q74572203 P698 Q74572203-7C9C13D7-A68D-49AE-AB39-4C1319372552 @default.
- Q74572203 P356 JCEM.87.8.8783 @default.
- Q74572203 P698 12161524 @default.
- Q74572203 P1433 Q3186902 @default.
- Q74572203 P1476 "Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis" @default.
- Q74572203 P2093 "Cheryl A Conover" @default.
- Q74572203 P2093 "F John Ballard" @default.
- Q74572203 P304 "3867-3870" @default.
- Q74572203 P31 Q13442814 @default.
- Q74572203 P356 "10.1210/JCEM.87.8.8783" @default.
- Q74572203 P407 Q1860 @default.
- Q74572203 P433 "8" @default.
- Q74572203 P478 "87" @default.
- Q74572203 P50 Q42164143 @default.
- Q74572203 P577 "2002-08-01T00:00:00Z" @default.
- Q74572203 P698 "12161524" @default.